These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
347 related articles for article (PubMed ID: 36233030)
1. Pathogenic Roles of Heparan Sulfate and Its Use as a Biomarker in Mucopolysaccharidoses. Minami K; Morimoto H; Morioka H; Imakiire A; Kinoshita M; Yamamoto R; Hirato T; Sonoda H Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233030 [TBL] [Abstract][Full Text] [Related]
2. The Enzymatic Degradation of Heparan Sulfate. Griffin LS; Gloster TM Protein Pept Lett; 2017; 24(8):710-722. PubMed ID: 28741461 [TBL] [Abstract][Full Text] [Related]
3. Glycosaminoglycan levels in dried blood spots of patients with mucopolysaccharidoses and mucolipidoses. Kubaski F; Suzuki Y; Orii K; Giugliani R; Church HJ; Mason RW; Dũng VC; Ngoc CT; Yamaguchi S; Kobayashi H; Girisha KM; Fukao T; Orii T; Tomatsu S Mol Genet Metab; 2017 Mar; 120(3):247-254. PubMed ID: 28065440 [TBL] [Abstract][Full Text] [Related]
4. Heparan sulfate proteoglycans: The sweet side of development turns sour in mucopolysaccharidoses. De Pasquale V; Pavone LM Biochim Biophys Acta Mol Basis Dis; 2019 Nov; 1865(11):165539. PubMed ID: 31465828 [TBL] [Abstract][Full Text] [Related]
5. Anatomical changes and pathophysiology of the brain in mucopolysaccharidosis disorders. Bigger BW; Begley DJ; Virgintino D; Pshezhetsky AV Mol Genet Metab; 2018 Dec; 125(4):322-331. PubMed ID: 30145178 [TBL] [Abstract][Full Text] [Related]
6. Heparan sulfate and dermatan sulfate derived disaccharides are sensitive markers for newborn screening for mucopolysaccharidoses types I, II and III. de Ruijter J; de Ru MH; Wagemans T; Ijlst L; Lund AM; Orchard PJ; Schaefer GB; Wijburg FA; van Vlies N Mol Genet Metab; 2012 Dec; 107(4):705-10. PubMed ID: 23084433 [TBL] [Abstract][Full Text] [Related]
7. Quantification of Glycosaminoglycans in Urine by Isotope-Dilution Liquid Chromatography-Electrospray Ionization Tandem Mass Spectrometry. Zhang H; Young SP; Millington DS Curr Protoc; 2023 Mar; 3(3):e701. PubMed ID: 36929617 [TBL] [Abstract][Full Text] [Related]
8. Newborn screening and diagnosis of mucopolysaccharidoses. Tomatsu S; Fujii T; Fukushi M; Oguma T; Shimada T; Maeda M; Kida K; Shibata Y; Futatsumori H; Montaño AM; Mason RW; Yamaguchi S; Suzuki Y; Orii T Mol Genet Metab; 2013; 110(1-2):42-53. PubMed ID: 23860310 [TBL] [Abstract][Full Text] [Related]
9. Community consensus for Heparan sulfate as a biomarker to support accelerated approval in Neuronopathic Mucopolysaccharidoses. Muenzer J; Ho C; Lau H; Dant M; Fuller M; Boulos N; Dickson P; Ellinwood NM; Jones SA; Zanelli E; O'Neill C Mol Genet Metab; 2024 Aug; 142(4):108535. PubMed ID: 39018614 [TBL] [Abstract][Full Text] [Related]
10. Competitive binding of extracellular accumulated heparan sulfate reduces lysosomal storage defects and triggers neuronal differentiation in a model of Mucopolysaccharidosis IIIB. De Pasquale V; Scerra G; Scarcella M; D'Agostino M; Pavone LM Biochim Biophys Acta Mol Cell Res; 2021 Oct; 1868(11):119113. PubMed ID: 34329663 [TBL] [Abstract][Full Text] [Related]
11. Assessment of bone dysplasia by micro-CT and glycosaminoglycan levels in mouse models for mucopolysaccharidosis type I, IIIA, IVA, and VII. Rowan DJ; Tomatsu S; Grubb JH; Montaño AM; Sly WS J Inherit Metab Dis; 2013 Mar; 36(2):235-46. PubMed ID: 22971960 [TBL] [Abstract][Full Text] [Related]
12. Targeting Heparan Sulfate Proteoglycans as a Novel Therapeutic Strategy for Mucopolysaccharidoses. De Pasquale V; Sarogni P; Pistorio V; Cerulo G; Paladino S; Pavone LM Mol Ther Methods Clin Dev; 2018 Sep; 10():8-16. PubMed ID: 29942826 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of cerebrospinal fluid heparan sulfate as a biomarker of neuropathology in a murine model of mucopolysaccharidosis type II using high-sensitivity LC/MS/MS. Tanaka N; Kida S; Kinoshita M; Morimoto H; Shibasaki T; Tachibana K; Yamamoto R Mol Genet Metab; 2018 Sep; 125(1-2):53-58. PubMed ID: 30064964 [TBL] [Abstract][Full Text] [Related]
14. Glycosaminoglycans analysis in blood and urine of patients with mucopolysaccharidosis. Khan SA; Mason RW; Giugliani R; Orii K; Fukao T; Suzuki Y; Yamaguchi S; Kobayashi H; Orii T; Tomatsu S Mol Genet Metab; 2018 Sep; 125(1-2):44-52. PubMed ID: 29779903 [TBL] [Abstract][Full Text] [Related]
15. Arylsulfatase K inactivation causes mucopolysaccharidosis due to deficient glucuronate desulfation of heparan and chondroitin sulfate. Trabszo C; Ramms B; Chopra P; Lüllmann-Rauch R; Stroobants S; Sproß J; Jeschke A; Schinke T; Boons GJ; Esko JD; Lübke T; Dierks T Biochem J; 2020 Sep; 477(17):3433-3451. PubMed ID: 32856704 [TBL] [Abstract][Full Text] [Related]
16. The Unifying Hypothesis of Alzheimer's Disease: Heparan Sulfate Proteoglycans/Glycosaminoglycans Are Key as First Hypothesized Over 30 Years Ago. Snow AD; Cummings JA; Lake T Front Aging Neurosci; 2021; 13():710683. PubMed ID: 34671250 [TBL] [Abstract][Full Text] [Related]
17. Quantification of glycosaminoglycans in urine by isotope-dilution liquid chromatography-electrospray ionization tandem mass spectrometry. Zhang H; Young SP; Millington DS Curr Protoc Hum Genet; 2013; Chapter 17():Unit 17.12. PubMed ID: 23315926 [TBL] [Abstract][Full Text] [Related]
18. Novel heparan sulfate assay by using automated high-throughput mass spectrometry: Application to monitoring and screening for mucopolysaccharidoses. Shimada T; Kelly J; LaMarr WA; van Vlies N; Yasuda E; Mason RW; Mackenzie W; Kubaski F; Giugliani R; Chinen Y; Yamaguchi S; Suzuki Y; Orii KE; Fukao T; Orii T; Tomatsu S Mol Genet Metab; 2014; 113(1-2):92-9. PubMed ID: 25092413 [TBL] [Abstract][Full Text] [Related]
19. Elevated LysoGb3 Concentration in the Neuronopathic Forms of Mucopolysaccharidoses. Baydakova G; Ilyushkina A; Gaffke L; Pierzynowska K; Bychkov I; Ługowska A; Wegrzyn G; Tylki-Szymanska A; Zakharova E Diagnostics (Basel); 2020 Mar; 10(3):. PubMed ID: 32183018 [TBL] [Abstract][Full Text] [Related]
20. A straightforward, quantitative ultra-performance liquid chromatography-tandem mass spectrometric method for heparan sulfate, dermatan sulfate and chondroitin sulfate in urine: an improved clinical screening test for the mucopolysaccharidoses. Zhang H; Wood T; Young SP; Millington DS Mol Genet Metab; 2015 Feb; 114(2):123-8. PubMed ID: 25458519 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]